Advertisement

Complications of Pancreaticoduodenectomy

  • Kyla Terhune
  • Nipun B. Merchant
  • Alexander A. Parikh
Part of the M. D. Anderson Solid Tumor Oncology Series book series (MDA)

Although pancreaticoduodenectomy (PD) was initially performed by Kausch in 1909 and popularized by Allen Whipple in 1935, the operation was traditionally regarded with significant skepticism due to high mortality and morbidity rates. During the past two decades, however, PD has slowly gained acceptance as a safe and effective treatment modality for both malignant and benign diseases of the periampullary region. Due to advances in operative technique and perioperative care, perioperative mortality rates have generally declined from 25–30% to <5% at high-volume centers (1–3). Nevertheless, morbidity rates are still significant—between 30% and 50% in many series (1, 3–5). Given the poor overall survival even in successfully resected patients and the continued need for aggressive and often toxic adjuvant therapy regimens, the impact for postoperative morbidity on the patient’s quality of life as well their ability to receive these adjuvant therapies is even more significant. This chapter reviews the most common complications following PD including the diagnosis, risk factors, prevention, and treatment.

Keywords

Gastric Emptying Pancreatic Fistula Distal Pancreatectomy Pancreatic Resection Preoperative Biliary Drainage 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Balcom JHT, 2001, Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization. Arch Surg 136 (4): 391–398.PubMedGoogle Scholar
  2. 2.
    Cameron JL, 2006, One thousand consecutive pancreaticoduodenectomies. Ann Surg 244(1):10–15.PubMedGoogle Scholar
  3. 3.
    Winter JM, 2006, 1423 Pancreaticoduodenectomies for pancreatic cancer: a single- institution experience. J Gastrointest Surg 10 (9): 1199–1211.PubMedGoogle Scholar
  4. 4.
    Behrman SW, Rush BT, Dilawari RA. 2004, A modern analysis of morbidity after pancreatic resection. Am Surg 70(8):675–682; discussion 682-683.PubMedGoogle Scholar
  5. 5.
    Schmidt CM, 2004, Pancreaticoduodenectomy: a 20-year experience in 516 patients. Arch Surg 139(7):718–725; discussion 725-727.PubMedGoogle Scholar
  6. 6.
    Billingsley KG, 2003, Outcome after pancreaticoduodenectomy for periampullary cancer: an analysis from the Veterans Affairs National Surgical Quality Improvement Program. J Gastrointest Surg 7(4):484–491.PubMedGoogle Scholar
  7. 7.
    Adam U, 2004, Risk factors for complications after pancreatic head resection. Am J Surg 187(2):201–208.PubMedGoogle Scholar
  8. 8.
    Bottger TC, Junginger T, 1999, Factors influencing morbidity and mortality after pancreaticoduodenectomy: critical analysis of 221 resections. World J Surg 23 (2): 164–171; discussion 171-172.PubMedGoogle Scholar
  9. 9.
    Fong Y, 1995, Pancreatic or liver resection for malignancy is safe and effective for the elderly. Ann Surg 222(4):426–434; discussion 434-437.PubMedGoogle Scholar
  10. 10.
    DiCarlo V, 1998, Pancreatic cancer resection in elderly patients. Br J Surg 85 (5): 607–610.PubMedGoogle Scholar
  11. 11.
    Makary MA, 2006, Pancreaticoduodenectomy in the very elderly. J Gastrointest Surg 10 (3):347–356.PubMedGoogle Scholar
  12. 12.
    Di Carlo V, 1999, Pylorus-preserving pancreaticoduodenectomy versus conventional whipple operation. World J Surg 23(9):920–925.PubMedGoogle Scholar
  13. 13.
    Roder JD, 1992, Pylorus-preserving versus standard pancreatico-duodenectomy: an analysis of 110 pancreatic and periampullary carcinomas. Br J Surg 79(2):152–155.PubMedGoogle Scholar
  14. 14.
    Schafer Μ, Mullhaupt B, Clavien PA, 2002, Evidence-based pancreatic head resection for pancreatic cancer and chronic pancreatitis. Ann Surg 236 (2): 137–148.PubMedGoogle Scholar
  15. 15.
    Ohwada S, 2001, Low-dose erythromycin reduces delayed gastric emptying and improves gastric motility after Billroth I pylorus-preserving pancreaticoduodenectomy. Ann Surg 234 (5):668–674.PubMedGoogle Scholar
  16. 16.
    Horstmann O, 1999, Is delayed gastric emptying following pancreaticoduodenectomy related to pylorus preservation? Langenbecks Arch Surg 384 (4): 354–359.PubMedGoogle Scholar
  17. 17.
    Riediger H, 2003, Delayed gastric emptying after pylorus-preserving pancreatoduodenectomy is strongly related to other postoperative complications. J Gastrointest Surg 7 (6):758–765.PubMedGoogle Scholar
  18. 18.
    Berge Henegouwen MI, van 1997, Delayed gastric emptying after standard pancreaticoduodenectomy versus pylorus-preserving pancreaticoduodenectomy: an analysis of 200 consecutive patients. J Am Coll Surg 185(4):373–379.PubMedGoogle Scholar
  19. 19.
    Goei TH, 2001, Pylorus-preserving pancreatoduodenectomy: influence of a Billroth I versus a Billroth II type of reconstruction on gastric emptying. Dig Surg 18(5):376–380.PubMedGoogle Scholar
  20. 20.
    Jimenez RE, 2000, Outcome of pancreaticoduodenectomy with pylorus preservation or with antrectomy in the treatment of chronic pancreatitis. Ann Surg 231(3):293–300.PubMedGoogle Scholar
  21. 21.
    Park YC, 2003, Factors influencing delayed gastric emptying after pylorus-preserving pan-creatoduodenectomy. J Am Coll Surg 196 (6): 859–865.PubMedGoogle Scholar
  22. 22.
    Lin PW, 2005, Pancreaticoduodenectomy for pancreatic head cancer: PPPD versus Whipple procedure. Hepatogastroenterology 52(65):1601–1604.PubMedGoogle Scholar
  23. 23.
    Tran KT, 2004, Pylorus preserving pancreaticoduodenectomy versus standard Whipple proce-dure: a prospective, randomized, multicenter analysis of 170 patients with pancreatic and periampullary tumors. Ann Surg 240(5):738–745.PubMedGoogle Scholar
  24. 24.
    Seiler CA, 2005, Randomized clinical trial of pylorus-preserving duodenopancreatectomy versus classical Whipple resection-long term results. Br J Surg 92(5):547–556.PubMedGoogle Scholar
  25. 25.
    Fischer CP, Hong JC. 2006, Method of pyloric reconstruction and impact upon delayed gastric emptying and hospital stay after pylorus-preserving pancreaticoduodenectomy. J Gastrointest Surg 10(2):215–219.PubMedGoogle Scholar
  26. 26.
    Kim DK, 2005, Is pylorospasm a cause of delayed gastric emptying after pylorus- preserving pancreaticoduodenectomy? Ann Surg Oncol 12 (3): 222–227.PubMedGoogle Scholar
  27. 27.
    Horstmann O, 2004, Pylorus preservation has no impact on delayed gastric emptying after pancreatic head resection. Pancreas 28 (1): 69–74.PubMedGoogle Scholar
  28. 28.
    Tani Μ, 2006, Improvement of delayed gastric emptying in pylorus-preserving pancreaticoduodenectomy: results of a prospective, randomized, controlled trial. Ann Surg 243 (3):316–320.PubMedGoogle Scholar
  29. 29.
    Shan YS, 2005, Effects of somatostatin prophylaxis after pylorus-preserving pancreaticoduo-denectomy: increased delayed gastric emptying and reduced plasma motilin. World J Surg 29 (10):1319–1324.PubMedGoogle Scholar
  30. 30.
    Berge Henegouwen MI, van 1997, The effect of octreotide on gastric emptying at a dosage used to prevent complications after pancreatic surgery: a randomised, placebo controlled study in volunteers. Gut 41 (6): 758–762.PubMedCrossRefGoogle Scholar
  31. 31.
    Dumitrascu DL, 1998, The effect of metoclopramide on antral emptying of a semisolid meal in patients with functional dyspepsia. A randomized placebo controlled sonographic study. Rom J Intern Med 36(1-2):97–104.Google Scholar
  32. 32.
    Erbas T, 1993, Comparison of metoclopramide and erythromycin in the treatment of diabetic gastroparesis. Diabetes Care 16(11):1511–1514.PubMedGoogle Scholar
  33. 33.
    Jooste CA, Mustoe J, Collee G, 1999, Metoclopramide improves gastric motility in critically ill patients. Intensive Care Med 25 (5): 464–468.PubMedGoogle Scholar
  34. 34.
    Malagelada JR, 1980, Gastric motor abnormalities in diabetic and postvagotomy gastropare-sis: effect of metoclopramide and bethanechol. Gastroenterology 78 (2): 286–293.PubMedGoogle Scholar
  35. 35.
    Metzger WH, Cano R, Sturdevant RA, 1976, Effect of metoclopramide in chronic gastric retention after gastric surgery. Gastroenterology 71 (1): 30–32.PubMedGoogle Scholar
  36. 36.
    Ricci DA, 1985, Effect of metoclopramide in diabetic gastroparesis. J Clin Gastroenterol 7(1):25–32.PubMedGoogle Scholar
  37. 37.
    Yeo CJ, 1993, Erythromycin accelerates gastric emptying after pancreaticoduodenectomy. A prospective, randomized, placebo-controlled trial. Ann Surg 218 (3): 229–237; discussion 237-238.PubMedGoogle Scholar
  38. 38.
    Buchler MW, 1995, Randomized trial of duodenum-preserving pancreatic head resection versus pylorus-preserving Whipple in chronic pancreatitis. Am J Surg 169(1):65–69; discussion 69-70.PubMedGoogle Scholar
  39. 39.
    Kazanjian KK, 2005, Management of pancreatic fistulas after pancreaticoduodenectomy: results in 437 consecutive patients. Arch Surg 140(9):849–854; discussion 854-856.PubMedGoogle Scholar
  40. 40.
    Lin JW, 2004, Risk factors and outcomes in postpancreaticoduodenectomy pancreaticocutane-ous fistula. J Gastrointest Surg 8(8):951–959.PubMedGoogle Scholar
  41. 41.
    Aranha GV, 2006, Current management of pancreatic fistula after ancreaticoduodenectomy. Surgery 140(4):561–568; discussion 568-569.PubMedGoogle Scholar
  42. 42.
    Yeh TS, 1997, Pancreaticojejunal anastomotic leak after pancreaticoduodenectomy--multi-variate analysis of perioperative risk factors. J Surg Res 67 (2): 119–125.PubMedGoogle Scholar
  43. 43.
    Srivastava S, 2001, Determinants of pancreaticoenteric anastomotic leak following pancreaticoduodenectomy. ANZ J Surg 71(9):511–515.PubMedGoogle Scholar
  44. 44.
    Bassi C, 2001, Management of complications after pancreaticoduodenectomy in a high volume centre: results on 150 consecutive patients. Dig Surg 18 (6): 453–457; discussion 458.PubMedGoogle Scholar
  45. 45.
    Tajima Y, 2006, Risk factors for pancreatic anastomotic leakage: the significance of preoperative dynamic magnetic resonance imaging of the pancreas as a predictor of leakage. J Am Coll Surg 202(5):723–731.PubMedGoogle Scholar
  46. 46.
    Berge Henegouwen MI, van 1997, Incidence, risk factors, and treatment of pancreatic leakage after pancreaticoduodenectomy: drainage versus resection of the pancreatic remnant. J Am Coll Surg 185(1):18–24.PubMedGoogle Scholar
  47. 47.
    Yang YM, 2005, Risk factors of pancreatic leakage after pancreaticoduodenectomy. World J Gastroenterol 11(16):2456–2461.PubMedGoogle Scholar
  48. 48.
    Kim SW, Youk EG, Park YH, 1997, Comparison of pancreatogastrostomy and pancreatojeju-nostomy after pancreatoduodenectomy performed by one surgeon. World J Surg 21 (6):640–643.PubMedGoogle Scholar
  49. 49.
    Oussoultzoglou E, 2004, Pancreaticogastrostomy decreased relaparotomy caused by pancreatic fistula after pancreaticoduodenectomy compared with pancreaticojejunostomy. Arch Surg 139 (3):327–335.PubMedGoogle Scholar
  50. 50.
    Schlitt HJ, 2002, Morbidity and mortality associated with pancreatogastrostomy and pan-creatojejunostomy following partial pancreatoduodenectomy. Br J Surg 89( 10):1245–1251.PubMedGoogle Scholar
  51. 51.
    Takano S, 2000, Pancreaticojejunostomy versus pancreaticogastrostomy in reconstruction following pancreaticoduodenectomy. Br J Surg 87(4):423–427.PubMedGoogle Scholar
  52. 52.
    Yeo CJ, 1995, A prospective randomized trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy. Ann Surg 222(4):580–588; discussion 588-592.PubMedGoogle Scholar
  53. 53.
    Bassi C, 2005, Reconstruction by pancreaticojejunostomy versus pancreaticogastrostomy following pancreatectomy: results of a comparative study. Ann Surg 242 (6): 767–771, discussion 771-773.PubMedGoogle Scholar
  54. 54.
    Bassi C, 2003, Duct-to-mucosa versus end-to-side pancreaticojejunostomy reconstruction after pancreaticoduodenectomy: results of a prospective randomized trial. Surgery 134 (5):766–771.PubMedGoogle Scholar
  55. 55.
    Roder JD, 1999, Stented versus nonstented pancreaticojejunostomy after pancreatoduodenectomy: a prospective study. Ann Surg 229(1):41–48.PubMedGoogle Scholar
  56. 56.
    Imaizumi T, 2002, Stenting is unnecessary in duct-to-mucosa pancreaticojejunostomy even in the normal pancreas. Pancreatology 2 (2): 116–121.PubMedGoogle Scholar
  57. 57.
    Kram HB, 1991, Fibrin glue sealing of pancreatic injuries, resections, and anastomoses. Am J Surg 161(4):479–481; discussion 482.PubMedGoogle Scholar
  58. 58.
    Tashiro S, 1987, New technique for pancreaticojejunostomy using a biological adhesive. Br J Surg 74(5):392–394.PubMedGoogle Scholar
  59. 59.
    Suzuki Y, 1995, Fibrin glue sealing for the prevention of pancreatic fistulas following distal pancreatectomy. Arch Surg 130(9):952–955.PubMedGoogle Scholar
  60. 60.
    D’Andrea AA, 1994, Human fibrin sealant in pancreatic surgery: it is useful in preventing fistulas? A prospective randomized study. Ital J Gastroenterol 26 (6): 283–286.PubMedGoogle Scholar
  61. 61.
    Suc B, 2003, Temporary fibrin glue occlusion of the main pancreatic duct in the prevention of intra-abdominal complications after pancreatic resection: prospective randomized trial. Ann Surg 237(1):57–65.PubMedGoogle Scholar
  62. 62.
    Lillemoe KD, 2004, Does fibrin glue sealant decrease the rate of pancreatic fistula after pan-creaticoduodenectomy? Results of a prospective randomized trial. J Gastrointest Surg 8 (7):766–772;discussion 772-774.PubMedGoogle Scholar
  63. 63.
    Klempa I, Schwedes U, Usadel KH. 1979, ( Prevention of postoperative pancreatic complica-tions following duodenopancreatectomy using somatostatin). Chirurg 50(7):427–431.PubMedGoogle Scholar
  64. 64.
    Buchler Μ, 1992, Role of octreotide in the prevention of postoperative complications following pancreatic resection. Am J Surg 163(1):125–130; discussion 130-131.PubMedGoogle Scholar
  65. 65.
    Friess H, 1995, Randomized controlled multicentre study of the prevention of complications by octreotide in patients undergoing surgery for chronic pancreatitis. Br J Surg 82 (9):1270–1273.PubMedGoogle Scholar
  66. 66.
    Gouillat C, 2001, Randomized controlled multicentre trial of somatostatin infusion after pan-creaticoduodenectomy. Br J Surg 88(11):1456–1462.PubMedGoogle Scholar
  67. 67.
    Montorsi Μ, 1995, Efficacy of octreotide in the prevention of pancreatic fistula after elective pancreatic resections: a prospective, controlled, randomized clinical trial. Surgery 117 (1):26–31.PubMedGoogle Scholar
  68. 68.
    Pederzoli P, 1994, Efficacy of octreotide in the prevention of complications of elective pan-creatic surgery. Italian Study Group. Br J Surg 81(2):265–269.Google Scholar
  69. 69.
    Li-Ling J, Irving Μ. 2001, Somatostatin and octreotide in the prevention of postoperative pancreatic complications and the treatment of enterocutaneous pancreatic fistulas: a system-atic review of randomized controlled trials. Br J Surg 88(2):190–199.PubMedGoogle Scholar
  70. 70.
    Lowy AM, 1997, Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease. Ann Surg 226(5):632–641.PubMedGoogle Scholar
  71. 71.
    Ramos-De la Medina A, Sarr MG. 2006, Somatostatin analogues in the prevention of pancreas-related complications after pancreatic resection. J Hepatobiliary Pancreat Surg 13 (3):190–193.PubMedGoogle Scholar
  72. 72.
    Sarr MG, 2003, The potent somatostatin analogue vapreotide does not decrease pancreas-specific complications after elective pancreatectomy: a prospective, multicenter, double-blinded, randomized, placebo-controlled trial. J Am Coll Surg 196 (4): 556–564; discussion 564-565; author reply 565.PubMedGoogle Scholar
  73. 73.
    Yeo CJ, 2000, Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial. Ann Surg 232 (3): 419–429.PubMedGoogle Scholar
  74. 74.
    Suc B, 2004, Octreotide in the prevention of intra-abdominal complications following elective pancreatic resection: a prospective, multicenter randomized controlled trial. Arch Surg 139 (3):288–294; discussion 295.PubMedGoogle Scholar
  75. 75.
    Martineau P, Shwed JA, Denis R. 1996, Is octreotide a new hope for enterocutaneous and external pancreatic fistulas closure? Am J Surg 172(4):386–395.PubMedGoogle Scholar
  76. 76.
    Nubiola-Calonge P, 1987, Blind evaluation of the effect of octreotide (SMS 201-995), a soma-tostatin analogue, on small-bowel fistula output. Lancet 2 (8560): 672–674.PubMedGoogle Scholar
  77. 77.
    Torres AJ, 1992, Somatostatin in the management of gastrointestinal fistulas. A multicenter trial. Arch Surg 127(1):97–99; discussion 100.Google Scholar
  78. 78.
    Gerardo Perez D, Bernardo AcostaΜ, 1994, (Gastrointestinal fistulas. Treatment with a somatostatin analogue) (SMS 201-995). G E N 48 (4): 209–218.PubMedGoogle Scholar
  79. 79.
    Hernandez-Aranda JC, 1996, (Treatment of enterocutaneous fistula with or without octreotide and parenteral nutrition). Nutr Hosp 11 (4): 226–229.PubMedGoogle Scholar
  80. 80.
    Balachandran P, 2004, Haemorrhagic complications of pancreaticoduodenectomy. ANZ J Surg 74(11):945–950.PubMedGoogle Scholar
  81. 81.
    Rumstadt B, 1998, Hemorrhage after pancreatoduodenectomy. Ann Surg 227 (2): 236–241.PubMedGoogle Scholar
  82. 82.
    Wente MN, 2006, Management of early hemorrhage from pancreatic anastomoses after pancreaticoduodenectomy. Dig Surg 23(4):203–208.PubMedGoogle Scholar
  83. 83.
    Choi SH, 2004, Delayed hemorrhage after pancreaticoduodenectomy. J Am Coll Surg 199(2):186–191.PubMedGoogle Scholar
  84. 84.
    Tien YW, 2005, Risk factors of massive bleeding related to pancreatic leak after pancreaticoduodenectomy. J Am Coll Surg 201 (4): 554–559.PubMedGoogle Scholar
  85. 85.
    Yoon YS, 2003, Management of postoperative hemorrhage after pancreatoduodenectomy. Hepatogastroenterology 50(54):2208–2212.PubMedGoogle Scholar
  86. 86.
    Berge Henegouwen MI, van 1995, Delayed massive haemorrhage after pancreatic and biliary surgery. Br J Surg 82(11):1527–1531.PubMedGoogle Scholar
  87. 87.
    Sohn TA, 2000, Resected adenocarcinoma of the pancreas—616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 4 (6): 567–579.PubMedGoogle Scholar
  88. 88.
    Barber GR, 1995, Direct observations of surgical wound infections at a comprehensive cancer center. Arch Surg 130(10):1042–1047.PubMedGoogle Scholar
  89. 89.
    Tonelli F, 2002, Amoxicillin/clavulanic acid versus cefotaxime for antimicrobial prophylaxis in abdominal surgery: a randomized trial. J Chemother 14 (4): 366–372.PubMedGoogle Scholar
  90. 90.
    Wille-Jorgensen P, 2005, Pre-operative mechanical bowel cleansing or not? An updated meta-analysis. Colorectal Dis 7(4):304–310.PubMedGoogle Scholar
  91. 91.
    Cameron JL, 1993, One hundred and forty-five consecutive pancreaticoduodenectomies without mortality. Ann Surg 217(5):430–435; discussion 435-438.PubMedGoogle Scholar
  92. 92.
    Miedema BW, 1992, Complications following pancreaticoduodenectomy. Current management. Arch Surg 127(8):945–949; discussion 949-950.Google Scholar
  93. 93.
    Sohn TA, 2003, Pancreaticoduodenectomy: role of interventional radiologists in managing patients and complications. J Gastrointest Surg 7 (2): 209–219.PubMedGoogle Scholar
  94. 94.
    Stephens J, 1997, Surgical morbidity, mortality, and long-term survival in patients with peripancreatic cancer following pancreaticoduodenectomy. Am J Surg 174(6):600–603; discussion 603-604.PubMedGoogle Scholar
  95. 95.
    Heslin MJ, 1998, Is intra-abdominal drainage necessary after pancreaticoduodenectomy? J Gastrointest Surg 2(4):373–378.PubMedGoogle Scholar
  96. 96.
    Conlon KC, 2001, Prospective randomized clinical trial of the value of intraperitoneal drain-age after pancreatic resection. Ann Surg 234 (4):487–493; discussion 493-494.PubMedGoogle Scholar
  97. 97.
    Kawai Μ, 2006, Early removal of prophylactic drains reduces the risk of intra-abdominal infections in patients with pancreatic head resection: prospective study for 104 consecutive patients. Ann Surg 244(1):1–7.PubMedGoogle Scholar
  98. 98.
    Cortes A, 2006, Effect of bile contamination on immediate outcomes after pancreaticoduo-denectomy for tumor. J Am Coll Surg 202 (1): 93–99.PubMedGoogle Scholar
  99. 99.
    Heslin MJ, 1998, A preoperative biliary stent is associated with increased complications after pancreatoduodenectomy. Arch Surg 133(2):149–154.PubMedGoogle Scholar
  100. 100.
    Hodul P, 2003, The effect of preoperative biliary stenting on postoperative complications after pancreaticoduodenectomy. Am J Surg 186(5):420–425.PubMedGoogle Scholar
  101. 101.
    Pisters PW, 2001, Effect of preoperative biliary decompression on pancreaticoduodenectomy-associated morbidity in 300 consecutive patients. Ann Surg 234(1):47–55.PubMedGoogle Scholar
  102. 102.
    Povoski SP, 1999, Association of preoperative biliary drainage with postoperative outcome following pancreaticoduodenectomy. Ann Surg 230 (2):131–142.PubMedGoogle Scholar
  103. 103.
    Smith RC, 1985, Preoperative percutaneous transhepatic internal drainage in obstructive jaundice: a randomized, controlled trial examining renal function. Surgery 97 (6):641–648.PubMedGoogle Scholar
  104. 104.
    Hatfield AR, 1982, Preoperative external biliary drainage in obstructive jaundice. A prospective controlled clinical trial. Lancet 2 (8304): 896–899.PubMedGoogle Scholar
  105. 105.
    Lai EC, 1994, Preoperative endoscopic drainage for malignant obstructive jaundice. Br J Surg 81(8):1195–1198.PubMedGoogle Scholar
  106. 106.
    McPherson GA, 1984, Pre-operative percutaneous transhepatic biliary drainage: the results of a controlled trial. Br J Surg 71(5):371–375.PubMedGoogle Scholar
  107. 107.
    Pitt HA, 1985, Does preoperative percutaneous biliary drainage reduce operative risk or increase hospital cost? Ann Surg 201(5):545–553.PubMedGoogle Scholar
  108. 108.
    Sewnath ME, 2002, A meta-analysis on the efficacy of preoperative biliary drainage for tumors causing obstructive jaundice. Ann Surg 236(1):17–27.PubMedGoogle Scholar
  109. 109.
    Karsten TM, 1996, Preoperative biliary drainage, colonisation of bile and postoperative complications in patients with tumours of the pancreatic head: a retrospective analysis of 241 consecutive patients. Eur J Surg 162(11):881–888.PubMedGoogle Scholar
  110. 110.
    Sewnath ME, 2001, The effect of preoperative biliary drainage on postoperative complications after pancreaticoduodenectomy. J Am Coll Surg 192(6):726–734.PubMedGoogle Scholar
  111. 111.
    Sohn TA, 2000, Do preoperative biliary stents increase postpancreaticoduodenectomy complications? J Gastrointest Surg 4 (3): 258–267; discussion 267-268.PubMedGoogle Scholar
  112. 112.
    Howard TJ, 2006, Influence of bactibilia after preoperative biliary stenting on postoperative infectious complications. J Gastrointest Surg 10 (4):523–531.PubMedGoogle Scholar
  113. 113.
    Jagannath P, 2005, Effect of preoperative biliary stenting on immediate outcome after pancreaticoduodenectomy. Br J Surg 92(3):356–361.PubMedGoogle Scholar
  114. 114.
    Gerndt SJ, Orringer MB, 1994, Tube jejunostomy as an adjunct to esophagectomy. Surgery 115(2):164–169.PubMedGoogle Scholar
  115. 115.
    Tapia J, 1999, Jejunostomy: techniques, indications, and complications. World J Surg 23(6):596–602.PubMedGoogle Scholar
  116. 116.
    Ishikawa O, 1989, Clinical and histopathological appraisal of preoperative irradiation for adenocarcinoma of the pancreatoduodenal region. J Surg Oncol 40 (3): 143–151.PubMedGoogle Scholar
  117. 117.
    Cheng TY, 2006, Effect of neoadjuvant chemoradiation on operative mortality and morbidity for pancreaticoduodenectomy. Ann Surg Oncol 13 (1): 66–74.PubMedGoogle Scholar
  118. 118.
    Leach SD, 1998, Survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic head. Br J Surg 85(5):611–617.PubMedGoogle Scholar
  119. 119.
    Riediger H, 2006, Postoperative morbidity and long-term survival after pancreaticoduodenectomy with superior mesenterico-portal vein resection. J Gastrointest Surg 10(8):1106–115.PubMedGoogle Scholar
  120. 120.
    Shibata C, 2001, Pancreatectomy combined with superior mesenteric-portal vein resection for adenocarcinoma in pancreas. World J Surg 25(8):1002–1005.PubMedGoogle Scholar
  121. 121.
    Tseng JF, 2004, Pancreaticoduodenectomy with vascular resection: margin status and survival duration. J Gastrointest Surg 8(8):935–949; discussion 949-950.PubMedGoogle Scholar
  122. 122.
    Birkmeyer JD, 2003, Surgeon volume and operative mortality in the United States. N Engl J Med 349(22):2117–2127.PubMedGoogle Scholar
  123. 123.
    Gouma DJ, 2000, Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume. Ann Surg 232 (6): 786–795.PubMedGoogle Scholar
  124. 124.
    Lieberman MD, 1995, Relation of perioperative deaths to hospital volume among patients undergoing pancreatic resection for malignancy. Ann Surg 222 (5): 638–645.PubMedGoogle Scholar
  125. 125.
    Rosemurgy AS, 2001, Frequency with which surgeons undertake pancreaticoduodenectomy determines length of stay, hospital charges, and in-hospital mortality. J Gastrointest Surg 5(1):21–26.PubMedGoogle Scholar
  126. 126.
    Shan YS, Sy ED, Lin PY, 2003, Role of somatostatin in the prevention of pancreatic stump-related morbidity following elective pancreaticoduodenectomy in high-risk patients and elimination of surgeon-related factors: prospective, randomized, controlled trial. World J Surg 27(6):709–714.PubMedGoogle Scholar
  127. 127.
    Hesse UJ, 2005, Prospectively randomized trial using perioperative low-dose octreotide to prevent organ-related and general complications after pancreatic surgery and pancreaticojejunostomy. World J Surg 29(10):1325–1328.PubMedGoogle Scholar

Copyright information

© Springer Science + Business Media, LLC 2008

Authors and Affiliations

  • Kyla Terhune
    • 1
  • Nipun B. Merchant
    • 1
  • Alexander A. Parikh
    • 1
  1. 1.Vanderbilt University School of MedicineNashvilleUSA

Personalised recommendations